Two people can buy a Medicare Supplement Insurance policy carrying the exact same letter, from two different insurance companies, and pay premiums that differ by hundreds of dollars a year for identical coverage. That gap isn’t a pricing error or a marketing trick. Federal standardization guarantees the benefits behind each Medigap letter are the same everywhere; it guarantees nothing at all about what an insurer is allowed to charge for delivering them.
Ten Letters, One Federally Fixed Benefit Package Each
Medicare Supplement Insurance, sold by private insurers to work alongside Original Medicare, comes in a set of standardized plans identified by letters. Medicare’s own plan-benefit comparison chart shows exactly which costs each lettered plan covers, from Part A hospital coinsurance to the Part B deductible to a portion of foreign travel emergencies, and that chart applies no matter which company sells the policy or which state a buyer lives in.
The standardization is deliberate and total: an insurance company selling Plan G in one state must offer the identical set of covered benefits as every other company selling Plan G anywhere else that uses the standard system. A buyer comparing Plan G quotes from three different insurers is comparing three identical benefit packages, which is precisely what lets price become the only meaningful variable in that comparison.
Two older letters carry a wrinkle worth knowing. Plans C and F, once popular because they covered the Part B deductible in full, are no longer sold to anyone who became eligible for Medicare on or after January 1, 2020. People who were eligible before that date can still buy or keep those plans, but newer enrollees choosing among the standardized options today simply don’t have access to those two.
Free retirement updates: One number can cost or save hundreds a month in retirement. The free Retirement Shield newsletter surfaces the ones worth knowing. Sign up free.
Why Identical Coverage Still Produces Wildly Different Bills
Because the benefits are locked by federal standardization, price competition among Medigap insurers happens entirely on the business side of the ledger: underwriting practices, administrative overhead, projected claims for that insurer’s specific pool of policyholders, and how aggressively a company prices new business to win market share. None of that touches what the policy actually pays, which is why the spread in premiums for a supposedly identical plan can be so wide.
States also regulate how insurers are allowed to price a standardized plan as policyholders age, and the main pricing methods produce very different long-term cost curves. Some insurers price everyone the same regardless of age at purchase, others set the price based only on the age someone bought in, and others increase the premium every year as the policyholder ages, a difference that compounds over a decade or two of ownership far more than the sticker price at signup suggests.
The practical result, confirmed on Medicare’s own explanation of how Medigap works, is that a Medigap policy is guaranteed renewable as long as premiums are paid, regardless of new health problems that develop later. That guarantee is valuable, but it means a policyholder who picked the higher-priced insurer at 65 is generally stuck paying that company’s rates unless they go through medical underwriting again to switch.
The One Window Where Comparison Shopping Has Real Teeth
Standardization solves the benefit-comparison problem, but it does nothing about medical underwriting, which is where most of the long-term premium difference actually gets locked in. Federal rules guarantee a limited window, beginning when a person turns 65 and enrolls in Part B, during which an insurer selling Medigap in that state must sell any policy it offers to that person regardless of health history, and typically at its standard rate for a new enrollee.
Outside that window, insurers in most states are legally permitted to ask health questions, charge more, or deny coverage outright based on a buyer’s medical history. Someone who delays comparing Medigap insurers, assuming the standardized benefits mean the choice of company doesn’t matter, can find that by the time they do shop around, a manageable health condition has already narrowed which insurers will take them at any price.
Medicare spells out exactly which situations qualify for guaranteed-issue protection after that initial window closes. A beneficiary who tries a Medicare Advantage plan for the first time gets a twelve-month trial right to switch back to Original Medicare and buy any Medigap policy sold in the state, health history aside; the same protection covers someone who loses employer, retiree, COBRA, or union coverage that had been paying secondary to Medicare. Medicare’s own guidance on when to buy a Medigap policy notes that most of these triggered guaranteed-issue windows last only 63 days from the qualifying event, a narrow enough gap that a policyholder who sets the notice letter aside can lose the protection before ever using it.
That asymmetry is why the standardization system rewards shopping early rather than shopping often. Because the covered benefits under a given letter never change from one insurer to the next, the entire decision comes down to comparing premiums, financial stability, and customer service across companies selling the identical plan, a comparison that only stays open on the most favorable terms for a matter of months after a person first becomes eligible.
This article was researched and drafted with the assistance of artificial intelligence.
More Financial Reading
